Cereno Scientific AB logo

CRNO TO1 B - Cereno Scientific AB News Story

SEK0.499 0.0  0.2%

Last Trade - 22/01/21

Sector
Healthcare
Size
Micro Cap
Market Cap £6.90m
Enterprise Value £6.24m
Revenue £n/a
Position in Universe 1690th / 1874

BRIEF-Cereno Scientific Signs Agreement With Inorbit Therapeutics

Tue 10th December, 2019 2:35pm
Dec 10 (Reuters) - Cereno Scientific AB  CRNOSb.TE :
    * CERENO SCIENTIFIC BROADENS ITS PIPELINE - SIGNS AGREEMENT
ON
ACQUISITION OF COMPOUND IN PRECLINICAL PHASE
    * CERENO SCIENTIFIC BROADENS ITS PIPELINE - SIGNS AGREEMENT
ON
ACQUISITION OF COMPOUND IN PRECLINICAL PHASE
    * ANNOUNCED TODAY THAT COMPANY HAS SIGNED AN AGREEMENT WITH
INORBIT THERAPEUTICS AB REGARDING ACQUISITION OF A NEW COMPOUND
IN PRECLINICAL PHASE
    * COMPOUND CS036 PROVIDES A FURTHER EXTENSION OF CERENO
SCIENTIFIC'S PORTFOLIO IN CARDIOVASCULAR DISEASES.
    * AGREEMENT WITH INORBIT THERAPEUTICS MEANS THAT CERENO
SCIENTIFIC
WILL TAKE OVER ALL RIGHTS RELATED TO COMPOUND AND RELATED
COMPOUND FAMILY

Source text for Eikon:  ID:nWkrbF7sx6 
Further company coverage:  CRNOSb.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.